DoujinStars
The Long Investor
The Long Investor

patreon


$PFE ** TOP 10 LIST FOR 2025**

Number 10, it had to be $PFE.

Legacy sector leader, at a 22 year low, fantastic dividend, oversold and drastically below its 200 WMA.

I upload $PFE a lot so we know that the major risk here is that the price can still flush down to the 0.78 Fib at $22 and the yellow support line that has been in place since 1990, yes 35 years ago but if does happen, the dividend will continue to increase and will make this even more attractive and certainly a stock you could buy and never sell.

$PFE always appears to be in the right place for every epidemic and any lag they find themselves in should be seen as an opportunity and the situation they are in now is very similar to 2008, where the price tested the yellow support line at $10 and then bounced up to $61 a decade later.

$PFE consistently have a number of drugs ready to finalise Phase 3 and they have prepared for their next cycle by buying Seagen in late 2023 for $43 Billion, which focuses on the Cancer market.  

So finally, this is the Weekly chart:

$PFE  ** TOP 10 LIST FOR 2025**

Comments

Approaching bottom trend line and increased dividend above 7

Teej

Couple of questions / thoughts worth thinking about on the risk side for this one and echoing what DC's comment said above: 1. Will $PFE stay profitable in the coming years with lower uptake of Covid products due to all the info that continues to come out about negative effects, injury, and death? 2. Will $PFE stay profitable if government funding and the sales of Covid products fall away with the new gov administration? 3. What legal and liability battles are on the horizon around Covid products that can beat the share price down even further? 4. What happens to profitability and cash flow if the new gov administration pulls pharma advertising from TV? Not sure if this one would be too much of a worry since the advertising is a biz expense. Technicals look great, but I think there are a lot of risks to this one as an investment in the next 4 years.

Gh0stSpeed

I agree with all the above. I like the name. Not adding as I see a massive potential liability from COVID Vax. This could get political and made an example by the Trump Administration. I know I'm sounding like a fearmonger but wanted to share with group.

DC

Discounted Cash Flow Model calculates at $77, which is the standard way to calculate Fair Value

Gareth Neary

Fair value of $77?! In what world do you get a fair value anywhere close to this? Historical PE puts this at $39. For it to get to 77 the PE would have to be double what it has been anytime in the last twenty years. Heck even during covid craziness the PE didn't get past 14. You'd need double that to get to $77 with their current earnings trajectory.

Limpy


More Creators